Research
Energy balance
23% of participants reported any adverse event while using GLP-1RAs, with 7% discontinuing treatment.
While GLP-1RAs are generally well-tolerated, practitioners should monitor for adverse events.
StrongQualifiesmedium confidence
23% (95% CI, 10%-36%) of participants reported any adverse event but only 7% discontinued treatment.
Why this rating
Based on a systematic review and meta-analysis of 17 studies.
Source
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
Caroline K. Kramer et al. · The Journal of Clinical Endocrinology & Metabolism · 2024
DOI 10.1210/clinem/dgae176
Meta-analysisCited 23×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →